Merck's outlook for 2026 comes in lower-than-expected as pipeline faces make-or-break year

Core Viewpoint - Merck's stock has declined due to full-year revenue and profit forecasts falling short of market expectations [1] Group 1: Financial Performance - The company's full-year revenue outlook is below expectations, indicating potential challenges in meeting market demands [1] - Profit forecasts for the year also did not meet analyst predictions, contributing to the stock decline [1] Group 2: Market Reaction - Following the announcement of the disappointing outlook, Merck's stock experienced a notable drop, reflecting investor concerns [1]